Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Aug;29(8):489-94.
doi: 10.1007/BF00453499.

Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats

Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats

H J Hahn et al. Diabetologia. 1986 Aug.

Abstract

This study investigated if and to what extent the acute toxic effect of Cyclosporin A on pancreatic Wistar rat B cells is reversible. After 2 weeks of treatment rats developed marked glucose intolerance accompanied by reduced pancreatic insulin content due to a loss of B cells, diminished islet DNA synthesis and decreased B-cell insulin content. Cyclosporin A had accumulated in the pancreas. Three weeks after withdrawal of Cyclosporin A, pancreatic tissue concentrations of Cyclosporin A were still 100 times larger than in serum. Glucose tolerance, however, had already improved, associated with an increase of B-cell insulin content and apparent islet replication, and the insulin response of isolated islets was reduced. Five weeks after the withdrawal of Cyclosporin A, glucose tolerance was normal, but pancreatic insulin content and relative B-cell volume were still diminished in comparison to vehicle-treated controls. Eight weeks after withdrawal, the morphometric parameters had also been normalized. The results suggest that the loss of pancreatic B cells is caused by a toxic destruction, possibly combined with an apparent decrease of replicatory activity. The acute toxic effects of Cyclosporin A in pancreatic B cells are stepwise reversible.

PubMed Disclaimer

References

    1. Med Res Rev. 1984 Apr-Jun;4(2):221-65 - PubMed
    1. J Biol Chem. 1958 Jul;233(1):184-8 - PubMed
    1. Acta Biol Med Ger. 1982;41(12):1171-7 - PubMed
    1. Lancet. 1985 Jan 12;1(8420):67-71 - PubMed
    1. Transplant Proc. 1984 Jun;16(3):709-12 - PubMed

Publication types